Genea Limited is a locally owned public company, deriving revenue from the provision of assisted reproductive technology products and services, and research and development activities in reproductive science and medicine. The company employs approximately 440 people, operates in Australia, New Zealand, Thailand, the United Kingdom, Hong Kong and the United States, and is administered from its head office in Sydney.

Genea Limited is an international provider of assisted reproductive technologies and undertakes medical fertility research and development. The group offers fertility-related goods and services through three segments:

Genea Fertility

  • Intrauterine Insemination (IUI)
  • Assisted Insemination (AI)
  • Ovulation induction (OI)
  • In-vitro fertilisation  (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Vitrification of genetic materials such as eggs, sperm, and embryos
  • Egg Freezing
  • Donor & surrogacy services
  • Genetic testing & prenatal screening
  • Holistic treatments, fitness programs & counselling

Genea Biomedx

  • Vitrification instruments
  • Embryo monitoring systems
  • IVF and Vitrification media
  • Double witnessing

Genea Biocells

  • Neuromuscular-focused drug development using stem cell technologies

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

Table of Contents

Company Details
Key Personnel
Growth & Ratios
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.